Attached files

file filename
EX-32.1 - EXHIBIT 32.1 - VYNE Therapeutics Inc.ex321123117.htm
EX-31.2 - EXHIBIT 31.2 - VYNE Therapeutics Inc.ex312123117.htm
EX-31.1 - EXHIBIT 31.1 - VYNE Therapeutics Inc.ex311123117.htm
10-K - 10-K - VYNE Therapeutics Inc.mnlo12311710-k.htm


EXHIBIT 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM


We hereby consent to the incorporation by reference in Registration Statement No. 333-222758 on Form S-8 of Menlo Therapeutics Inc., of our report dated March 28, 2018, relating to the financial statements, which appear in this Form 10-K.

/s/ Mayer Hoffman McCann P.C.

San Diego, California
March 28, 2018